According to these results, we suggest that 4-DACL may be a promising therapeutic agent for the treatment of malignant melanoma.
No takes yet. Share an insight, caveat, or question.
Genov et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: